
Roche and Amgen have both posted successful late-stage trial results that they say will contribute to their applications for regulatory …
A treatment for patients with the most common form of leukaemia has been fast tracked by NICE because of strong …
Migraine annual economic and quality-of-life burden in UK
bit.bio expands human heart cell portfolio through myriamed partnership
Phoenix Labs acquires Kent Pharma
Astoriom acquires Sampled’s UK stability storage operations

